SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Gilead and Kite Present Pipeline Data at ASH 2026

The companies reported iMMagine-1 data with at least 18 months of follow-up on anito-cel durability and safety in relapsed disease.

GILD

Related stories